TM Bioscience

About:

Tm Bioscience is a DNA-based diagnostics company engaged in developing genetic tests for genetic mutations related to human disease.

Top Investors: Laurus Funds

Description:

Tm Bioscience Corporation, a DNA-based diagnostics company, engages in developing a suite of genetic tests principally in Canada and the United States. Its product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease. The company's primary product includes Tag-It Mutation Detection Kit for the P450-2D6 drug metabolism gene; Tag-It CFTR 40+4 mutation detection kit detecting 40 mutations and 4 variants in the Cystic Fibrosis gene; and a custom developed Cystic Fibrosis CFTR 70 test for specialty laboratories.